The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.
Platonova N.M.
Endocrinology Research Centre, Moscow, Russia
Makolina N.P.
FGBU Éndokrinologicheskiĭ nauchnyĭ tsentr Minzdravsotsrazvitiia RF, Moskva
Rybakova A.A.
Endocrinology Research Centre, Moscow, Russia
Troshina E.A.
Éndokrinologicheskiĭ nauchnyĭ tsentr, Moskva
Autoimmune thyroiditis and pregnancy: changes in the modern diagnostic and therapeutic paradigms
Journal: Russian Journal of Human Reproduction. 2020;26(1): 29‑38
Views: 85689
Downloaded: 1259
To cite this article:
Platonova NM, Makolina NP, Rybakova AA, Troshina EA. Autoimmune thyroiditis and pregnancy: changes in the modern diagnostic and therapeutic paradigms. Russian Journal of Human Reproduction.
2020;26(1):29‑38. (In Russ.)
https://doi.org/10.17116/repro20202601129
A sufficient level of thyroid hormones is crucial for normal course of pregnancy and fetal development. It has been proven that even subclinical thyroid dysfunction during pregnancy is associated with adverse outcomes for both mother and baby. The leading role in the development of thyroid dysfunction belongs to overt hypothyroidism in the outcome of autoimmune thyroiditis. Despite the progress achieved in the study of pathogenesis of this disease and the wide possibilities of using advanced laboratory technologies, there are currently a lot of diagnostic and clinical issues and uncertainties. Role of such markers, such as anti-TPO, thyroglobulin antibodies in the development and progression of hypothyroidism associated with obstetric complications and neuropsychiatric disorders in child. Also relevant is the issue of using high performance liquid chromatography MS/MS — tandem mass spectrometry (MS/MS) to develop trimester-specific intervals for thyroid hormones during pregnancy. In 2017, updated clinical guidelines were issued, in which experts discuss new reference values of TSH for pregnant women with an emphasis on ethnic features of the population. These recommendations change the diagnostic criteria and indications for initiating levothyroxine replacement therapy for treatment of hypothyroidism in pregnant women.
Keywords:
Authors:
Platonova N.M.
Endocrinology Research Centre, Moscow, Russia
Makolina N.P.
FGBU Éndokrinologicheskiĭ nauchnyĭ tsentr Minzdravsotsrazvitiia RF, Moskva
Rybakova A.A.
Endocrinology Research Centre, Moscow, Russia
Troshina E.A.
Éndokrinologicheskiĭ nauchnyĭ tsentr, Moskva
List of references:
Close metadata
Email Confirmation
An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.
Email Confirmation
Log in to the site using your account in one of the services
We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.